That figure includes costs related to the the Reston, Va.-based public sector health and human services contractor acquisitions of Acentia and Remploy, both of which closed in early April.
Without those expenses, Maximus said its earnings for the quarter were 62 cents per share and total profit was $42.25 million.
Maximus also posted $572.3 million in revenue for the quarter, a figure the company said includes organic growth and new business acquired through Acentia and Remploy.
Wall Street analysts projected revenue to be approximately $550.6 million.
Shares of Maximus traded at $69.40 as of 10:47 Eastern time Thursday.